Taprizosin (mesylate)

• Description:

  Taprizosin (UK-338003) mesylate is an α-adrenoreceptor antagonist[1].

• Product Name Alternative:

  UK-338003 (mesylate)

• UNSPSC:

  12352005

• Target:

  Adrenergic Receptor

• Related Pathways:

  GPCR/G Protein; Neuronal Signaling

• Field of Research:

  Neurological Disease; Cardiovascular Disease

• Smiles:

  CS (=O) (NC1=CC=CC2=C1CCN (C3=NC (N) =C4C (C5=NC=CC=C5) =C (OC) C (OC) =CC4=N3) C2) =O.CS (=O) (O) =O

• Molecular Formula:

  C26H30N6O7S2

• Molecular Weight:

  602.68

• References & Citations:

  [1]Collett A, et al. Investigation of regional mechanisms responsible for poor oral absorption in humans of a modified release preparation of the alpha-adrenoreceptor antagonist, 4-amino-6,7-dimethoxy-2- (5-methanesulfonamido-1,2,3,4 tetrahydroisoquinol-2-yl) -5- (2-pyridyl) quinazoline (UK-338,003) : the rational use of ex vivo intestine to predict in vivo absorption. Drug Metab Dispos. 2008 Jan;36 (1) :87-94.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• CAS Number:

  358632-25-4